-+ 0.00%
-+ 0.00%
-+ 0.00%

Is Nestlé (SWX:NESN) Undervalued Following Its Genpact AI Partnership?

Simply Wall St·07/16/2026 10:29:45
Listen to the news

Nestlé (SWX:NESN) is in focus after Genpact announced a partnership with Nestlé Business Solutions to build a new Global Capability Center in Hyderabad, India, centered on AI driven process transformation.

See our latest analysis for Nestlé.

Nestlé’s 30 day share price return of 6% and year to date share price return of 9.71% suggest momentum has been improving, while the 1 year total shareholder return of 13.53% contrasts with weaker 3 and 5 year total shareholder returns. This indicates a recovery phase that this new AI focused partnership may be helping to support.

If this kind of AI driven corporate shift has your attention, it could be a good moment to see which other companies are riding similar themes through our 63 profitable AI stocks that aren't just burning cash

After Nestlé’s recent share price rebound and renewed focus on AI enabled efficiency, the real tension now is simple: are investors still being paid enough for the risks, or has most of the upside already been priced in?

Most Popular Narrative: 7.9% Undervalued

According to one of the most followed Nestlé narratives, a fair value of CHF91.08 sits above the last close at CHF83.86. This puts this AI focused momentum in a wider long term context.

Nestlé is no longer a high-growth company, but a global compounder transforming toward higher-value nutrition categories. The key investment thesis is that Nestlé can gradually improve profitability through:

• Health Science,

• GLP-1 Nutrition,

• Pet Care,

• Premium Coffee,

• and Emerging Markets.

Read the complete narrative.

This narrative leans heavily on a specific blend of modest revenue growth, higher margins and a future earnings multiple that assumes Nestlé’s nutrition pivot gains real traction.

Result: Fair Value of CHF91.08 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this Nestlé narrative could be challenged if the shift toward higher value nutrition stalls, or if Health Science and pet care margins fail to materialise as expected.

Find out about the key risks to this Nestlé narrative.

Another Take On Nestlé’s Valuation

The user narrative sees Nestlé as around 7.9% undervalued at CHF91.08, yet our P/E based checks send a mixed message. Nestlé trades on a 23.9x P/E, above European food peers at 16.6x and slightly above a peer group at 22.9x, but below a fair ratio of 28.8x. Is that a safety margin or a warning sign that expectations are already rich?

For a closer look at how this ratio based view could shift if earnings or sentiment change, take a moment to review the valuation breakdown in our fair ratio workup. Then compare it with your own assumptions on Nestlé’s AI and nutrition story See what the numbers say about this price — find out in our valuation breakdown.

SWX:NESN P/E Ratio as at Jul 2026
SWX:NESN P/E Ratio as at Jul 2026

Next Steps

With sentiment around Nestlé split between opportunity and caution, this is a good moment to move quickly, study the data and form your own view using the 3 key rewards and 1 important warning sign.

Looking for more Nestlé investment ideas and beyond?

If Nestlé has sharpened your focus, do not stop here. Broaden your watchlist now or risk missing companies that better match your goals and risk comfort.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.